Prospective Evaluation of Optical Coherence Tomography Usage in the Screening of Eye Diseases
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 118
- 试验地点
- 1
- 主要终点
- OCT screening efficacy for detection of early stage eye diseases in comparison to the current standard of care methods
研究概览
简要总结
The primary goal of the trial is to show that optical coherence tomography (OCT) technology can be used to effectively screen for diseases of the eye including glaucoma, macular diseases and keratoconus. Glaucoma is a disease that causes permanent vision loss and is usually accompanied by increased eye pressure. Macular diseases affect sharp, central vision. Keratoconus is a disease that affects the cornea (clear surface covering the colored part of the eye).
详细描述
The identification of many eye diseases would significantly benefit from earlier detection than is available with typical eye exams. Optical coherence tomography (OCT) is an imaging technology that can perform non-contact cross-sectional imaging of tissue structure in real time. It is similar to ultrasound B-mode imaging, except that OCT measures the intensity of reflected light rather than sound waves.
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 89 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Participant undergoing a screening examination at the Casey Eye Institute Outreach Van.
- •Participants must be between the ages of 18 and 89 years old.
排除标准
- •Inability to give informed consent.
- •Inability to maintain stable fixation for OCT imaging
结局指标
主要结局
OCT screening efficacy for detection of early stage eye diseases in comparison to the current standard of care methods
时间窗: 1 year
The primary goal of the trial is to show that OCT technology, specifically the FDA cleared iVue, can be used to effectively screen for glaucoma, macular diseases and keratoconus. The rate of detection of these diseases detected using OCT will be compared to the rate of detection by the physician's exam.
次要结局
未报告次要终点
研究者
David Huang
Michael Chiang, MD, Professor, Provisional, Department of Ophthalmology and Medical Informatics & Clinical Epidemiology
Oregon Health and Science University